.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Teva
Queensland Health
Express Scripts
Baxter
Mallinckrodt
Federal Trade Commission
Chinese Patent Office
Moodys
Accenture

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202561

« Back to Dashboard
NDA 202561 describes CHLOROTHIAZIDE SODIUM, which is a drug marketed by Sun Pharma Global, Luitpold, Sagent Pharms, Mylan Institutional, and Fresenius Kabi Usa, and is included in five NDAs. It is available from five suppliers. Additional details are available on the CHLOROTHIAZIDE SODIUM profile page.

The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.

Summary for NDA: 202561

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202561

Ingredient-typeThiazides
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 202561

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLOROTHIAZIDE SODIUM
chlorothiazide sodium
INJECTABLE;INJECTION 202561 ANDA American Regent, Inc. 0517-1820 0517-1820-01 1 VIAL in 1 CARTON (0517-1820-01) > 18 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Apr 22, 2013TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Dow
Merck
UBS
Federal Trade Commission
Mallinckrodt
Deloitte
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot